Bruker Corporation

Equities

BRKR

US1167941087

Market Closed - Nasdaq Other stock markets 04:00:00 2026-01-16 pm EST			5-day change	1st Jan Change
48.39 ^USD	-2.16%		-11.15%	+2.72%

Jan. 12	Bruker Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 09:00 AM
Jan. 12	(BRKR) Bruker Expects Q4 Revenue Range $965M - $970M, vs. FactSet Est of $958.3M	MT

Transcript : Bruker Corporation Presents at 7th Annual Wolfe Research Healthcare Conference, Nov-17-2025 04

Published on 12/15/2025 at 10:45 am EST

S&P Capital IQ

Presenter Speech
Douglas Schenkel (Analysts)

All right. So I'm Doug from Wolfe Research. It's my pleasure to be joined here by Gerald Herman, Chief Financial Officer of Bruker Corporation. Joe Kostka,

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Bruker Corporation

Jan. 12	Bruker Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 09:00 AM
Jan. 12	(BRKR) Bruker Expects Q4 Revenue Range $965M - $970M, vs. FactSet Est of $958.3M	MT
Jan. 12	Bruker Corp expects 2026 organic revenue growth flat to low-single digits	RE
Jan. 09	Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for Mri	CI
Jan. 09	Bruker Unit Receives $500 Million in Orders for Superconductors	MT
Jan. 08	Bruker Acquires Complete Ownership of Tofwerk	MT
Jan. 07	Bruker Corporation acquired remaining majority stake Tofwerk AG.	CI
Dec. 22	Ri Research Instruments announces major orders for enabling technology for ELI-NP	RE
Dec. 22	HEDGE FLOW-Hedge funds short healthcare providers as subsidies debate intensifies	RE
Dec. 18	Abcellera and Bruker reach global settlement of patent litigation	RE
Dec. 18	AbCellera Biologics Says Bruker to Pay $36 Million Upfront in Patent Litigation Settlement	MT
Dec. 15	Bruker Corporation Presents at 7th Annual Wolfe Research Healthcare Conference, Nov-17-2025 04:00 PM
Dec. 10	Wolfe Research Upgrades Bruker to Outperform From Peer Perform, $60 Price Target	MT
Dec. 10	Bruker Receives $25 Million in European Orders for High-Performance Magnetic Resonance Systems	MT
Dec. 10	Bruker Corporation Receives Orders For High-Performance Magnetic Resonance Systems From École Normale Supérieure, Max Planck Institute For Solid-State Research, And Institut Européen De Chimie Et Biologie	CI
Dec. 10	Bruker Corporation Presents at 53rd Annual Nasdaq Investor Conference, Dec-10-2025 10:00 AM
Dec. 08	Bruker Announces the Addition of Jack Phillips to Its Board of Directors, Effective January 1, 2026	CI
Nov. 24	Bruker Corporation acquired AST Revolution, LLC from Indaba Capital Management, L.P.	CI
Nov. 24	Bruker Buys AST Revolution	MT
Nov. 20	Rothschild & Co Redburn Initiates Coverage on Bruker With Buy Rating, $60 Price Target	MT
Nov. 04	Bruker Corporation Approves Quarterly Common Stock Dividend, Payable on January 2, 2026	CI
Nov. 04	UBS Adjusts Price Target on Bruker to $43 From $40, Maintains Neutral Rating	MT
Nov. 04	The Bull Market Meets Its Therapist
Nov. 04	Analysts recommendations: Apple, Comcast, Crocs, Eli Lilly, Palantir…
Nov. 03	Bruker Corporation Updates Earnings Guidance for the Fiscal Year 2025	CI